- Home
- RNA vs ALVO Comparison
RNA vs ALVO Comparison
Compare RNA & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- ALVO
- Stock Information
- Founded
- RNA 2012
- ALVO 2013
- Country
- RNA United States
- ALVO Luxembourg
- Employees
- RNA N/A
- ALVO N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- RNA Health Care
- ALVO Health Care
- Exchange
- RNA Nasdaq
- ALVO Nasdaq
- Market Cap
- RNA 3.7B
- ALVO 3.4B
- IPO Year
- RNA 2020
- ALVO N/A
- Fundamental
- Price
- RNA $29.52
- ALVO $9.67
- Analyst Decision
- RNA Strong Buy
- ALVO Buy
- Analyst Count
- RNA 12
- ALVO 1
- Target Price
- RNA $68.25
- ALVO $18.00
- AVG Volume (30 Days)
- RNA 1.4M
- ALVO 116.9K
- Earning Date
- RNA 05-08-2025
- ALVO 03-26-2025
- Dividend Yield
- RNA N/A
- ALVO N/A
- EPS Growth
- RNA N/A
- ALVO N/A
- EPS
- RNA N/A
- ALVO N/A
- Revenue
- RNA $10,897,000.00
- ALVO $491,978,000.00
- Revenue This Year
- RNA N/A
- ALVO $399.41
- Revenue Next Year
- RNA $230.08
- ALVO $41.44
- P/E Ratio
- RNA N/A
- ALVO N/A
- Revenue Growth
- RNA 13.98
- ALVO 426.85
- 52 Week Low
- RNA $21.56
- ALVO $9.15
- 52 Week High
- RNA $56.00
- ALVO $14.76
- Technical
- Relative Strength Index (RSI)
- RNA 43.70
- ALVO 27.07
- Support Level
- RNA $30.12
- ALVO $11.07
- Resistance Level
- RNA $33.13
- ALVO $11.77
- Average True Range (ATR)
- RNA 2.14
- ALVO 0.42
- MACD
- RNA -0.05
- ALVO -0.13
- Stochastic Oscillator
- RNA 11.94
- ALVO 17.00
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.